is[1]Jemal A, Bray F, Center M M, et al. Global Cancer statistics[J]. CA Cancer J Clin, 2011,61(2):69 [2]Nguyen D X, Massague J. Genetic determinants of Cancer metastasis[J]. Nat Rev Genet, 2007,8(5):341 [3]D’souza R. Rajji TK,mulsant BH.pollock BG use of Lithium in the treatment of bipolar disorder in late-life[J]. Curr Psychiatry Rep J, 2011,13(6):488 [4]Filyak Y, Filyak O, Stoika R. Transforming growth factor beta-1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line[J]. Cell Biol Int, 2007,31(8):851 [5]Lan Y, Liu X, Zhang R, et al. Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells[J]. Biometals, 2013,26(2):241 [6]Hager E D, Dziambor H, Höhmann D, et al. Effects of Lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy[J]. Biol Trace Elem Res, 2001,83(2):139 [7]Hager E D, Dziambor H, Winkler P, et al. Effects of Lithium carbonate on hematopoietic cells in patients with persistent neutropenia following chemotherapy or radiotherapy[J]. Journal of Trace Elements in Medicine and Biology, 2002,16(2):91 [8]Gupta A, Schulze T G, Nagarajan V, et al. Interaction networks of Lithium tas [9]Beurel E, Blivet-Van Eggelpoël M J, Kornprobst M, et al. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells[J]. Biochem Pharmacol, 2009,77(1):54 [10]Liao X, Zhang L, Thrasher J B, et al. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate Cancer[J]. Mol Cancer Ther, 2003,2(11):1215 [11]Mego M, Mani S A, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer--clinical applications[J]. Nat Rev Clin Oncol, 2010,7(12):693 [12]Yamamoto H, Yoo S K, Nishita M, et al. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2[J]. Genes Cells, 2007,12(11):1215 [13]Zhan G F, Phiel C J, Spece L, et al. Inhibitory phosphorylation of glycogen synthase kinase-3(GSK-3)[J]. J Biol Chem, 2003,278(35):33067 [14]Gould T D, Gray N A, Manji H K. Effects of a glycogen synthase kinase-3 inhibitor, Lithium, in adenomatous polyposis coli mutant mice[J]. Pharmacol Res, 2003,48(1):49 [15]Beurel E, Kornprobst M, Blivet-Van Eggelpoël M J, et al. GSK-3beta inhibition by Lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression[J]. Exp Cell Res, 2004,300(2):354
[1]林高阳,徐 克.氯化锂调控人肺腺癌A549细胞增殖侵袭转移的体外研究[J].天津医科大学学报,2015,21(03):9.
LIN Gao-yang,XU Ke.Proliferation and invasion potentials of lung adenocarcinoma cell A549 regulated by lithium chloride in vitro[J].Journal of Tianjin Medical University,2015,21(01):9.
[2]赵青春,韦 森,张洪兵,等.分析第6版和第7版TNM分期在肺腺癌患者中的差异[J].天津医科大学学报,2015,21(05):432.
[3]高周勇,张文成,王广舜.基于TCGA数据库分析GTSE1基因在肺腺癌中的表达及意义[J].天津医科大学学报,2021,27(03):274.
GAO Zhou-yong,ZHANG Wen-cheng,WANG Guang-shun.Expression and significance of GTSE1 gene in lung adenocarcinoma based on TCGA database[J].Journal of Tianjin Medical University,2021,27(01):274.
[4]李世雄,耿华,徐美林.肿瘤微环境中免疫与基质细胞相关基因在肺腺癌中的预后价值[J].天津医科大学学报,2022,28(01):47.
LI Shi-xiong,GENG Hua,XU Mei-lin.Prognostic value of immune and stromal cell-related genes in tumor microenvironment in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(01):47.
[5]骆源,徐启飞,吕泽政,等.三维ResNet 网络预测肺腺癌结节亚型的效能及其
稳定性[J].天津医科大学学报,2022,28(03):295.
LUO Yuan,XU Qi-fei,LYU Ze-zheng,et al.Efficacy and stability of 3D ResNet for predicting nodule subtypes in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(01):295.
[6]马梦楚,任媛媛,刘欣.肺腺癌细胞中PRDM5抑癌作用的分子机制初探[J].天津医科大学学报,2022,28(04):360.
MA Meng-chu,REN Yuan-yuan,LIU Xin.Preliminary study on the molecular mechanism of PRDM5 suppression in lung adenocarcinoma[J].Journal of Tianjin Medical University,2022,28(01):360.
基金项目 国家自然科学基金资助项目(30873035);天津市教委重点资助项目(ZD200714);天津市科委重点资助项目(10JCZDJC20800) 作者简介 林高阳(1988-),男,硕士在读,研究方向:肺癌的侵袭转移; 通信作者:徐克,E-mail:lingaoyang1988@126.com。